- Home
- KLTR vs ALEC Comparison
KLTR vs ALEC Comparison
Compare KLTR & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KLTR | ALEC |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.0M | 228.7M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KLTR | ALEC |
|---|---|---|
| Price | $1.30 | $1.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $3.00 | ★ $4.83 |
| AVG Volume (30 Days) | 338.9K | ★ 879.4K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.90 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $180,854,000.00 | $21,045,000.00 |
| Revenue This Year | $2.96 | $2.03 |
| Revenue Next Year | $4.96 | $29.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.20 | N/A |
| 52 Week Low | $1.06 | $1.09 |
| 52 Week High | $2.02 | $3.40 |
Technical Indicators
Market Signals| Indicator | KLTR | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 36.74 |
| Support Level | $1.22 | $1.37 |
| Resistance Level | $1.54 | $1.60 |
| Average True Range (ATR) | 0.05 | 0.17 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 50.00 | 16.77 |
Price Performance
Historical ComparisonAbout KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.